COGT
Price
$31.02
Change
-$0.57 (-1.80%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
5.53B
39 days until earnings call
Intraday BUY SELL Signals
DMRA
Price
$20.67
Change
+$0.44 (+2.17%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
1.28B
28 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COGT vs DMRA

COGT vs DMRA Comparison Chart in %
View a ticker or compare two or three
VS
COGT vs. DMRA commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and DMRA is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
COGT vs DMRA: Fundamental Ratings
COGT
DMRA
OUTLOOK RATING
1..100
1558
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
2447
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
4436
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DMRA's Valuation (30) in the null industry is somewhat better than the same rating for COGT (74) in the Miscellaneous industry. This means that DMRA’s stock grew somewhat faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (24) in the Miscellaneous industry is in the same range as DMRA (47) in the null industry. This means that COGT’s stock grew similarly to DMRA’s over the last 12 months.

COGT's SMR Rating (99) in the Miscellaneous industry is in the same range as DMRA (99) in the null industry. This means that COGT’s stock grew similarly to DMRA’s over the last 12 months.

DMRA's Price Growth Rating (36) in the null industry is in the same range as COGT (44) in the Miscellaneous industry. This means that DMRA’s stock grew similarly to COGT’s over the last 12 months.

DMRA's P/E Growth Rating (100) in the null industry is in the same range as COGT (100) in the Miscellaneous industry. This means that DMRA’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTDMRA
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 5 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (COGT: $31.59 vs. DMRA: $20.23)
Brand notoriety: COGT and DMRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 81% vs. DMRA: 55%
Market capitalization -- COGT: $5.53B vs. DMRA: $1.28B
COGT [@Biotechnology] is valued at $5.53B. DMRA’s [@Biotechnology] market capitalization is $1.28B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 1 FA rating(s) are green while DMRA’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 1 green, 4 red.
  • DMRA’s FA Score: 1 green, 4 red.
According to our system of comparison, DMRA is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while DMRA’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 3 bearish.
  • DMRA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, COGT is a better buy in the short-term than DMRA.

Price Growth

COGT (@Biotechnology) experienced а +0.51% price change this week, while DMRA (@Biotechnology) price change was -0.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

COGT is expected to report earnings on Nov 10, 2026.

DMRA is expected to report earnings on Oct 30, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
COGT
Daily Signal:
Gain/Loss:
DMRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VSTL20.430.37
+1.84%
Defiance Daily Target 2X Long VST ETF (VSTL)
JHSC45.730.28
+0.62%
John Hancock Multifactor Small Cap ETF (JHSC)
EMC37.20-0.01
-0.02%
Global X Emerging Markets Great Consumer ETF (EMC)
IGF61.31-0.25
-0.41%
iShares Global Infrastructure ETF (IGF)
IDVZ32.56-0.44
-1.33%
Opal International Dividend Income ETF (IDVZ)

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with DMRA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then DMRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-1.34%
DMRA - COGT
49%
Loosely correlated
-4.93%
ENGN - COGT
47%
Loosely correlated
-1.00%
REPL - COGT
42%
Loosely correlated
+1.59%
VERA - COGT
40%
Loosely correlated
-4.03%
MLYS - COGT
39%
Loosely correlated
-5.61%
More

DMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMRA has been loosely correlated with COGT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DMRA jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMRA
1D Price
Change %
DMRA100%
-4.93%
COGT - DMRA
49%
Loosely correlated
-1.34%
NERV - DMRA
45%
Loosely correlated
-3.58%
INBX - DMRA
44%
Loosely correlated
-2.15%
RANI - DMRA
44%
Loosely correlated
+0.57%
GNTA - DMRA
38%
Loosely correlated
+14.80%
More